Cost-benefit analysis, Cost-Utility, Cost effectiveness and Global rate of perception for change after Extracorporeal Shockwave Therapy on Frozen Shoulder in Patients with Diabetes: Preliminary Randomized control Trial

In patients with diabetes mellitus (DM), adequate glucose control is of major importance. When treatment schemes become more complicated, proper self-management through intermittent self-measurement of blood glucose (SMBG), among others, becomes crucial in achieving this goal. In the last decade, continuous glucose monitoring (CGM) has been on the rise, providing not only intermittent information but also information on continuous glucose trends. The FreeStyle Libre (FSL) Flash CGM system is a CGM system mainly used for patients with DM and is designed based on the same techniques as early CGMs. Compared with earlier CGMs, the FSL is factory calibrated, has no automated readings or direct alarms, and is cheaper to use. Although less accurate compared with the gold standard for SMBG, users report high satisfaction because it is easy to use and can help users monitor glucose trends. The Flash Monitor Register in the Netherlands (FLARE-NL) study aims to assess the effects of FSL Flash CGM use in daily practice. The study has a before-after design, with each participant being his or her own control. Users will be followed for at least 1 year. The endpoints include changes in HbA1c, frequency and severity of hypoglycemias, and quality of life. In addition, the effects of its use on work absenteeism rate, diabetes-related hospital admission rate, and daily functioning (including sports performance) will be studied. Furthermore, cost-benefit analysis based on the combination of registered information within the health insurance data will be investigated. Ultimately, the data gathered in this study will help increase the knowledge and skills of the use of the Flash CGM in daily practice and assess the financial impact on the use of the Flash CGM within the Dutch healthcare system.

Download Full-text

Cost-Benefit Analysis of Internet Therapeutic Intervention on Patients With Diabetes

International Journal of Endocrinology and Metabolism ◽

10.5812/ijem.22803 ◽

2015 ◽

Vol 13 (2) ◽

Cited By ~ 5

Author(s):

Lan Deng ◽

Adam S. White ◽

Monika Pawlowska ◽

Betty Pottinger ◽

Jessica Aydin ◽

...

Keyword(s):

Therapeutic Intervention ◽

Cost Benefit Analysis ◽

Cost Benefit ◽

Benefit Analysis ◽

Patients With Diabetes

Download Full-text

Comparative Efficacy and Patient- Specific Moderating Factors of Nonsurgical Treatment Strategies for Frozen Shoulder: An Updated Systematic Review and Network Meta-analysis

The American Journal of Sports Medicine ◽

10.1177/0363546520956293 ◽

2020 ◽

pp. 036354652095629

Author(s):

Jie Zhang ◽

Shuchang Zhong ◽

Tongcai Tan ◽

Juebao Li ◽

Shuang Liu ◽

...

Keyword(s):

Pain Relief ◽

Steroid Injection ◽

Meta Analysis ◽

Frozen Shoulder ◽

Shoulder Function ◽

Functional Improvement ◽

Patient Specific ◽

Extracorporeal Shockwave Therapy ◽

Shockwave Therapy ◽

Moderating Factors

Background: Frozen shoulder is a common shoulder disorder characterized by pain and restriction. Various nonsurgical treatments have been reported, but there is no consensus about their comparative efficacy and the effects of moderators. Purpose: To compare the efficacy of different nonsurgical interventions and identify potential patient-specific moderating factors for frozen shoulder. Study Design: Systematic review and network meta-analysis. Methods: PubMed, Embase, Cochrane Library, and Web of Science databases were searched from their inception to February 18, 2019. The search was supplemented by manual review of relevant reference lists. Randomized controlled trials of participants with frozen shoulder that compared nonsurgical interventions were selected. Measured outcomes included pain, shoulder function in daily activities, and range of motion. Results: Of 3136 records identified, 92 trials were eligible, evaluating 32 nonsurgical interventions in 5946 patients. Intra-articular injection improved pain (pooled standardized mean difference [95% CI]: steroid injection, 1.68 [1.03-2.34]; capsular distension, 2.68 [1.32-4.05]) and shoulder function (steroid injection, 2.16 [1.52-2.81]; distension, 2.89 [1.71-4.06]) to a greater extent than placebo. Capsular distension and extracorporeal shockwave therapy showed the highest ranking for pain relief and functional improvement, respectively. Laser therapy also showed benefits for pain relief (3.02 [1.84-4.20]) and functional improvement (3.66 [1.65-5.67]). Subgroup analyses by disease stages revealed that steroid injection combined with physical therapy provided more benefits during the freezing phase, whereas joint manipulation provided more benefits in the adhesive phase. Adjunctive therapies, female sex, and diabetes were also identified as moderators of effectiveness. Conclusion: Capsular distension is a highly recommended choice for treatment of frozen shoulder, contributing greatly to pain relief and functional improvement; steroid injection is also a prevailing effective intervention. Among new options, extracorporeal shockwave therapy and laser therapy show potential benefits for multiple outcomes. Individualized optimal intervention should be considered, given that treatment effect is moderated by factors including the disease stage, time of assessment, adjunctive therapies, female sex, and diabetes.

Download Full-text

Economic Evaluations in the Canadian Mental Health System I: Theory behind Economic Evaluation*

The Canadian Journal of Psychiatry ◽

10.1177/070674378903400702 ◽

1989 ◽

Vol 34 (7) ◽

pp. 633-636 ◽

Cited By ~ 1

Author(s):

Bruce J. Fried ◽

Catherine Worthington ◽

Raisa B. Deber

Keyword(s):

Mental Health ◽

Economic Evaluation ◽

Health Program ◽

Cost Benefit Analysis ◽

Cost Benefit ◽

Cost Utility ◽

Economic Evaluations ◽

Utility Analysis ◽

Mental Health Programs

Economic evaluation is becoming an increasingly important part of the evaluation of health and mental health services. Current models for conducting economic evaluation, including cost-effectiveness analysis, cost-benefit analysis, and cost-utility analysis, have great potential for improving the quality of decision-making and for making mental health programs more effective and efficient. This paper presents the basic economic theory underlying the various forms of economic evaluation and provides general guidelines for developing and conducting an economic analysis of a health program.

Download Full-text

The study of Pharmacoeconomics analysis on anti tuberculosis drugs Rifampicin & Ethambutol

International Journal of Research in Hospital and Clinical Pharmacy ◽

10.33974/ijrhcp.v1i1.27 ◽

2018 ◽

Vol 1 (1) ◽

pp. 31-40

Author(s):

Arsalan Sarmad ◽

B. Syed Salman ◽

Syed Sharfuddin Ibrahim

Keyword(s):

Cost Effectiveness ◽

Cost Benefit Analysis ◽

Cost Minimization ◽

Cost Benefit ◽

Minimum Cost ◽

Cost Utility ◽

Cost Utility Analysis ◽

Effective Therapy ◽

Benefit Analysis ◽

Utility Analysis

Cost-benefit analysis can be used to quantify the value of clinical pharmacy services. Providing Effective Therapy and Minimum cost, Quantify costs of care, Quantify outcomes, Assess whether and by how much average costs and outcomes differ among treatment groups, Compare magnitude of difference in costs and outcomes and evaluate “value for costs” by reporting a cost-effectiveness ratio, net monetary benefit, or probability that ratio is acceptable – Potential hypothesis: Cost per quality-adjusted life year saved significantly less than Rs.75,000, To Perform sensitivity analysis. For providing good effective therapy with less adverse drug reaction at affordable price, Cost-Identification, Cost-Effectiveness Analysis, Cost-Utility Analysis, Cost-Benefit Analysis, Clinical outcomes: Cure, comfort and survival, Humanistic outcomes: Physical, emotional, social function, role performance, Economic outcomes, Economic Evaluation, Cost of Illness Evaluation (COI), Cost Benefit Analysis (CBA), Cost Minimization Analysis, Cost Effective Analysis: Cost Utility Analysis.

Download Full-text

Acquisition of a Dose Management System with Consideration of Medico-Legal and Economic Aspects

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ◽

10.1055/a-1710-3529 ◽

2021 ◽

Author(s):

Thuy Duong Do ◽

Claudius Melzig ◽

Hans-Ulrich Kauczor ◽

Marc-André Weber ◽

Mark Oliver Wielpütz

Keyword(s):

Cost Benefit Analysis ◽

Cost Benefit ◽

Steering Committee ◽

Cost Utility ◽

Cost Utility Analysis ◽

Current Status ◽

Actual Condition ◽

Utility Analysis ◽

Advantages And Disadvantages ◽

Dose Management

Background New radiation protection regulation encompassing additional obligations for monitoring, reporting and recording of radiation exposure, was enacted on December 31, 2018. As a consequence, dose management systems (DMS) are necessary to fulfill the requirements. The process of selection, acquisition and implementation of a suitable IT solution for this purpose is a challenge that all X-ray-applying facilities, including hospitals and private practices, are currently facing. Method A target/actual-analysis as well as a cost-utility analysis is presented for this specific case as a foundation for the acquisition decision-making process. Result An actual analysis is necessary in order to record the current status of dose documentation. An interdivisional approach is recommended to include all imaging modalities and devices. An interdisciplinary steering committee can be helpful in enabling consensus and rapid action. A target analysis includes additional criteria with respect to ease of operation, technical feasibility, process optimization and research opportunities to consider in addition to the statutory requirements. By means of a cost-benefit analysis, considerations between costs and the individually weighted advantages and disadvantages of eligible DMS result in a ranking of preference for the available solutions. Conclusion Requirements of a DMS can be summarized in a specification sheet. Deploying an actual condition analysis, target state analysis and cost-utility analysis can help to identify a suitable DMS to achieve rapid commissioning and highest possible user acceptance while optimizing costs at the same time. Key Points: Citation Format

Download Full-text

Health Economics of Vaccination and Immunization Practices

10.33442/vt202121 ◽

2021 ◽

Author(s):

Thomas Szucs

Keyword(s):

Cost Effectiveness ◽

Cost Benefit Analysis ◽

Cost Savings ◽

Cost Benefit ◽

Quality Adjusted Life Year ◽

Cost Utility ◽

Cost Effectiveness Analysis ◽

Vaccination Programs ◽

Effectiveness Analysis ◽

Wide Range

The economic importance of vaccines lies partly in the burden of disease that can be avoided and partly in the competition for resources between vaccines and other interventions. Decision-makers are increasingly demanding hard economic data as a basis for the allocation of limited healthcare resources. The main types of evaluation available are cost-benefit analysis (best use of allocated resources), cost-effectiveness analysis (a tool that helps policy-makers decide on the overall allocation of resources), and cost-utility analysis (quality-adjusted life year [QALY] which allows for a direct comparison of a wide range of medical interventions). The cost per QALY for a range of vaccinations can be compared in order to plan a vaccination program. Public health vaccines warrant a cost-benefit approach, in order to determine if they are worthwhile, whereas recommended vaccines might be more usefully assessed by cost-effectiveness analysis. Although cost-savings do not necessarily equate with cost-effectiveness, cost-savings are achieved in many vaccination programs.

Download Full-text